Avenue Therapeutics (NASDAQ:ATXI) just reported results for the second quarter of 2024.
- Avenue Therapeutics reported earnings per share of -$6.43. This was below the analyst estimate for EPS of -$1.05.
- The company did not report any revenue for the quarter.